Warthin tumor

Changed by Yuranga Weerakkody, 6 Jul 2017

Updates to Article Attributes

Body was changed:

Warthin tumours (or papillary cystadenoma lymphomatosum) are a benign, sharply demarcated tumour of the salivary- lymphoid origin most commonly arising from parotid gland tail. They are bilateral or multifocal in up to 20% of cases, and are the most common neoplastic cause of multiple solid parotid masses. 

Epidemiology

They are the 2nd most common (up to 10% of all parotid tumours) benign parotid tumour (after pleomorphic adenoma) and are the commonest bilateral or multifocal benign parotid tumour. It typically occurs in the elderly (6th decade). There is a recognised male predilection. Patients typically present with painless parotid swelling.

Morphology

They are often multicentric (20%) and are usually small (1-4 cm). They have a typically heterogeneous appearance on all modalities, often with cystic components (30%).

Location

Tends to favour the parotid tail region at the level of mandibular angle.

Associations
  • smoking
  • irradiation

Radiographic features

Has a greater tendency to undergo cystic change (~30%) than any other salivary gland tumour 4,5.

Ultrasound

Most tumours tend to be ovoid, had well-defined margins, contain multiple irregular, small, sponge-like anechoic areas 10. Tumours that are large (e.g. >5 cm) tend to have a higher proportion of cystic content than smaller lesions had and in some cases can be composed almost entirely of cystic material. They are often hypervascular.

CT
  • classic appearance is a well defined heterogeneous solid cystic lesion within the superficial lobe of parotid/parotid tail
  • well defined
  • no calcification
  • cystic changes appear as intra lesional lower attenuation
  • moderate enhancement
  • presence of mural nodule is strongly suggestive of Warthin tumour
  • can be often seen bilaterally
MRI

Well defined and can be bilateral. 

  • T1: low to intermediate signal with cyst containing cholesterol components containing focal high signal 2
  • T2: heterogenous and variable signal intensity
  • T1 C+ (Gd): usually no contrast enhancement 3
Nuclear medicine

Often shows uptake with Tc99-pertechnetate, thallium and FDG-PET 7.

Treatment and prognosis

They are benign with extremely low incidence of malignant transformation. Some advocate surgical excision while others favour conservative management with follow up imaging.

Differential diagnosis

Possible imaging differential considerations include:

  • -<a href="/articles/acinic-cell-carcinoma-of-salivary-glands">acinic cell carcinoma</a><a href="/articles/acinic-cell-carcinoma"> </a>(of salivary gland)</li>
  • +<a href="/articles/acinic-cell-carcinoma-salivary-glands">acinic cell carcinoma</a><a href="/articles/acinic-cell-carcinoma"> </a>(of salivary gland)</li>
Images Changes:

Image 7 CT (With-contrast) ( create )

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.